Fundraising FoxAshatherapeutics
1 known investors
Find your way into Ashatherapeutics
Sign up to see every warm intro you have to Ashatherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ashatherapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Asha Therapeutics uses physics-based computational methods to design drug molecules, operating at the intersection of computational chemistry and drug discovery. The company's approach aims to reduce time and cost in early-stage pharmaceutical development.
Founders & leadership
SS
Sam ShrivastavaFounder & Chief Executive Officer
BH
Bradlee Heckmann, Ph.D.President & Chief Scientific Officer | Scientific Co-Founder
RM
Rainer Metcalf, Ph.D.Chief Technology Officer | Scientific Co-Founder
Investors · 1
Frequently asked questions
- What does Ashatherapeutics do?
- Asha Therapeutics uses physics-based computational methods to design drug molecules, operating at the intersection of computational chemistry and drug discovery. The company's approach aims to reduce time and cost in early-stage pharmaceutical development.
- Who founded Ashatherapeutics?
- Ashatherapeutics was founded by Sam Shrivastava, Bradlee Heckmann, Ph.D., Rainer Metcalf, Ph.D..
- Who are Ashatherapeutics's investors?
- Ashatherapeutics's investors include ATP.